Brain & Nervous System Stroke How tPA Works for Stroke Tissue plasminogen activator is a treatment to bust clots By Jose Vega MD, PhD Jose Vega MD, PhD LinkedIn Jose Vega MD, PhD, is a board-certified neurologist and published researcher specializing in stroke. Learn about our editorial process Updated on March 03, 2023 Medically reviewed by Nicholas R. Metrus, MD Medically reviewed by Nicholas R. Metrus, MD LinkedIn Nicholas R. Metrus, MD, is board-certified in neurology and neuro-oncology. He currently works at the Glasser Brain Tumor Center with Atlantic Health System in Summit, New Jersey. Learn about our Medical Expert Board Print Table of Contents View All Table of Contents What It Does Eligibility Timeframe for Use Side Effects Getting Treatment Frequently Asked Questions Tissue plasminogen activator (tPA) is a drug given through a vein to help break up a blood clot so that blood flow can return to normal. It is used for the emergency treatment of ischemic stroke, which occurs when a blood clot interrupts blood flow to a region of the brain. The timely administration of tPA can save lives. And because tPA restores blood flow by dissolving the clots in a blood vessel, it may limit the damage from a stroke and protect against quality of life impacts, like mobility loss or speech difficulties. This article explains what tPA is and how it works to break down a clot. It discusses how healthcare providers make a decision about tPA administration, why it's not always possible to use the drug, and the side effects and complications that may arise from tPA use. Chris Ryan / Getty Images What tPA Does A protein that naturally occurs in the body, tPA can be found on endothelial cells—the cells that line blood vessels. It activates the conversion of plasminogen to plasmin, an enzyme responsible for the breakdown of clots. This helps restore blood flow that would otherwise remain impeded. An experienced medical team can administer tPA in its powerful medication form when rapid clot-busting is needed. Due to a range of factors, including the availability of tPA, the death rate from stroke in the United States fell 77% between 1969 and 2013. Recovery from a stroke after tPA treatment may still take quite some time, however. Life After Stroke Who Can Get tPA? Prior to receiving treatment with tPA, you should expect your healthcare provider to review your medical history and order a brain computerized tomography (CT) scan. This is because there are several medical conditions that make it too dangerous for you to receive tPA. If you have any of these conditions, not only would tPA not help you, it could cause significant harm to your health. You are ineligible to receive treatment if any of the following apply: Hemorrhagic stroke (bleeding in the brain) Brain aneurysm or AVM Previous intracranial hemorrhage Symptoms of a subarachnoid hemorrhage Recent history of surgical procedure Head injury/trauma History of stroke in the last three months Bleeding or blood clotting disorder Bleeding ulcer Pregnancy Use of blood-thinning medication Uncontrolled high blood pressure (above 185/110 mmHg) Low blood sugar (below 50 mg/dL) Protocols have been established to rapidly identify whether you could be having a stroke, so that your testing and treatment can be prompt and efficient, allowing you to receive life-saving treatments in a timely manner. In fact, some centers are making strides in diagnosing stroke sooner than ever before via mobile stroke units. Timeframe for Administration Treatment with tPA has been effective for people with an ischemic stroke as long as it is received intravenously within up to 4.5 hours of the onset of symptoms. In contrast, endovascular treatment to remove the clot or deliver tPA at the site of the clot is considered for up to 24 hours after a stroke. Guidelines for the treatment of acute stroke published by the American Heart Association in 2018 strongly recommend IV alteplase (tPA) within 4.5 hours of stroke symptoms onset for eligible patients. This treatment approach has been shown to produce the best overall outcomes. Side Effects of tPA While tPA has been shown to be beneficial in the treatment of stroke, there are risks associated with tPA treatment—even for people who have been medically cleared to receive it. It is a powerful blood thinner, and serious side effects may occur, including the following: Hemorrhage (bleeding) affecting the brain: Causes headaches, weakness, confusion, loss of consciousness, seizuresHemorrhage of the digestive system: Causes blood in the stool or stomach painSevere blood loss: Causes lightheadedness, low blood pressure, loss of consciousnessMinor bleeding in the gums or noseBlood in the urine If you experience any of these side effects, you should immediately inform your medical team. Getting Prompt tPA Treatment The best way to maximize the chances of receiving the most effective treatment for a stroke is to get to the emergency room as soon as possible if you believe a stroke may be occurring. Symptoms of a stroke include: Trouble understanding words or speakingNumbness of the arm, face, or legBlurred or blackened vision in one or both eyesDouble visionSudden, severe headacheVomitingDizzinessDifficulty walkingLoss of balance or coordinationWeakness of the face, arm, or legDroopy face or eyelidConfusion Note that a person having a stroke may not notice when they are experiencing symptoms. You may recognize these signs in someone else before they do, or vice versa. Don’t wait for the symptoms to disappear. The sooner you get help, the more likely you'll be in the window for tPA treatment (if applicable). You'll also likely have fewer the long-term effects. Signs and Symptoms of Stroke A Word From Verywell The use of tPA medication to break up clots in blood vessels has offered benefits to thousands of people since its use was first approved, but it can't be used in all cases. It's important to recognize the signs and symptoms of stroke to ensure treatment begins as quickly as possible. Frequently Asked Questions What kind of drug is tPA? As a thrombolytic, tPA is part of a drug class that also includes agents such as TNKase (tenecteplase) and Streptase (streptokinase). These drugs are used to induce thrombolysis, or the dissolving of blood clots. Learn More: What Is Thromboembolism? What is tPA used for? Tissue plasminogen activator (tPA) is used to treat ischemic stroke, pulmonary embolism, and heart attack. Why is tPA not given after 4.5 hours? Research suggests tPA administered after 4.5 hours is not beneficial and may increase the risk of death. Some studies are investigating if tPA administration after 4.5 may provide benefits in certain situations. Stroke Recovery and Rehabilitation 9 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. UptoDate. Patient education: Ischemic stroke treatment (Beyond the Basics). American Stroke Association. Why getting quick stroke treatment is important. National Institute of Neurological Disorders and Stroke. Tissue Plasminogen Activator for Acute Ischemic Stroke. Merck Manual Consumer Version. Ischemic stroke. Powers WJ, Rabinstein AA, Ackerson T, et al; American Heart Association Stroke Council. 2018 guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018 Mar;49(3):e46-e110. doi: 10.1161/STR.0000000000000158. Fernandez-Gotico H, Lightfoot T, Meighan M. Multicenter study of adverse events after intravenous tissue-type plasminogen activator treatment of acute ischemic stroke. J Neurosci Nurs. 2017;49(1):31-36. doi:10.1097/JNN.0000000000000247 American Stroke Association. Stroke symptoms. Chen QF, Liu YY, Pan CS, Fan JY, Yan L, Hu BH, Chang X, Li Q, Han JY. Angioedema and Hemorrhage After 4.5-Hour tPA (Tissue-Type Plasminogen Activator) Thrombolysis Ameliorated by T541 via Restoring Brain Microvascular Integrity. Stroke. 2018;49(9):2211-2219. doi:10.1161/STROKEAHA.118.021754 Wechsler LR. The 4.5-hour time window for intravenous thrombolysis with intravenous tissue-type plasminogen activator is not firmly established. Stroke. 2014;45(3):914–5. doi:10.1161/STROKEAHA.113.002701 Additional Reading Christophe BR, Mehta SH, Garton AL, Sisti J, Connolly ES Jr. Current and future perspectives on the treatment of cerebral ischemia. Expert Opin Pharmacother. 2017;18(6):573-580. doi:10.1080/14656566.2017.1309022 By Jose Vega MD, PhD Jose Vega MD, PhD, is a board-certified neurologist and published researcher specializing in stroke. See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit